Yizhou Dong, PhDProfessor, Icahn Genomics Institute at Icahn School of Medicine at Mount Sinai
Yizhou Dong is a Professor at the Icahn School of Medicine at Mount Sinai. His research focuses on the design and development of biotechnology platforms for the treatment of genetic disorders, infectious diseases, and cancers. Dr. Dong has authored over one hundred papers and patents. Several of his inventions have been licensed and are currently under development as drug candidates for clinical trials. He serves as a scientific advisory board member for Oncorus Inc, Arbor Biotechnologies, and FL85. Dr. Dong is an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE).
Lipid Nanoparticles for mRNA therapeutics, Cancer Immunotherapy and Cell Therapy, 11:15amView Session